Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Rolland

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Current Opinion in HIV and AIDS|March 30, 2019
HIV-1 phylogenetics and vaccinesMorgane Rolland
AIDS Research and Human Retroviruses|September 10, 2011
Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provideMorgane Rolland, Peter Gilbert
AIDS (London, England)|June 20, 2015
Multiple co-circulating HIV-1 subtypes in the Middle East and North AfricaMorgane Rolland, Kayvon Modjarrad
Virus Evolution|November 9, 2019
A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicityEric Lewitus, Morgane Rolland
Med (New York, N.Y.)|May 19, 2022
Does HIV-1 virulence matter in the ART era?Eric Lewitus, Morgane Rolland
Science Advances|January 18, 2023
Design of a pan-betacoronavirus vaccine candidate through a phylogenetically informed approachEric Lewitus, Hongjun Bai, Morgane Rolland
Virus Evolution|January 31, 2025
HIV-1 Vif global diversity and possible APOBEC-mediated response since 1980Eric Lewitus, Yifan Li, Morgane Rolland
Current Opinion in HIV and AIDS|April 18, 2009
Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine designJames I Mullins, Morgane Rolland, Todd M Allen
Current Opinion in HIV and AIDS|May 31, 2013
Sieve analysis in HIV-1 vaccine efficacy trialsPaul T Edlefsen, Peter B Gilbert, Morgane Rolland
Trends in Immunology|June 6, 2017
T Cell Immunity and Zika Virus Vaccine DevelopmentNoemia S Lima, Morgane Rolland, Kayvon Modjarrad, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Current Opinion in HIV and AIDS|March 30, 2019
HIV-1 phylogenetics and vaccinesMorgane Rolland
AIDS Research and Human Retroviruses|September 10, 2011
Evaluating immune correlates in HIV type 1 vaccine efficacy trials: what RV144 may provideMorgane Rolland, Peter Gilbert
AIDS (London, England)|June 20, 2015
Multiple co-circulating HIV-1 subtypes in the Middle East and North AfricaMorgane Rolland, Kayvon Modjarrad
Virus Evolution|November 9, 2019
A non-parametric analytic framework for within-host viral phylogenies and a test for HIV-1 founder multiplicityEric Lewitus, Morgane Rolland
Med (New York, N.Y.)|May 19, 2022
Does HIV-1 virulence matter in the ART era?Eric Lewitus, Morgane Rolland
Science Advances|January 18, 2023
Design of a pan-betacoronavirus vaccine candidate through a phylogenetically informed approachEric Lewitus, Hongjun Bai, Morgane Rolland
Virus Evolution|January 31, 2025
HIV-1 Vif global diversity and possible APOBEC-mediated response since 1980Eric Lewitus, Yifan Li, Morgane Rolland
Current Opinion in HIV and AIDS|April 18, 2009
Viral evolution and escape during primary human immunodeficiency virus-1 infection: implications for vaccine designJames I Mullins, Morgane Rolland, Todd M Allen
Current Opinion in HIV and AIDS|May 31, 2013
Sieve analysis in HIV-1 vaccine efficacy trialsPaul T Edlefsen, Peter B Gilbert, Morgane Rolland
Trends in Immunology|June 6, 2017
T Cell Immunity and Zika Virus Vaccine DevelopmentNoemia S Lima, Morgane Rolland, Kayvon Modjarrad, et al.
Pageof 12